YDYanhua Du

Yanhua Du

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yanhua Du has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Jun Wu

    Department of Laboratory Medicine, Jiading Branch of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    2 shared publications
  • Bingnan Lu

    Department of Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China

    1 shared publication
  • Han Liu

    Department of Laboratory Medicine, Jiading Branch of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    1 shared publication
  • Haonan Ma

    Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China

    1 shared publication
  • Qiuxiang Zhou

    Department of Emergency and Critical Care, Shanghai Changzheng Hospital, Naval Military Medical University, Shanghai, China

    1 shared publication
  • Rulin Zhang

    Department of Laboratory Medicine, Jiading Branch of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201803, China

    1 shared publication

Latest Publications

  • Open Access

    Uncovering stromal cell fate genes and a novel risk stratification in UCEC by integrating single-cell RNA sequencing and multi-omics analysis

    by Rulin Zhang, Haonan Ma, Yiting Yang, Siang Lv, Xin Guan, Bingnan Lu, Yuntao Yao, Runzhi Huang, Yifan Liu, Yanhua Du, et al.

  • Open Access

    ASPM and TROAP gene expression as potential malignant tumor markers

    by Han Liu, Qiuxiang Zhou, Xiang Xu, Yanhua Du, Jun Wu

    Background: Although increasing evidence supports a vital role for assembly factor for spindle microtubules (ASPM) and trophinin-associated protein (TROAP) in the tumorigenesis of some cancers, no systematic pancancer analyses of ASPM and TROAP have been performed. Thus, we aimed to investigate the potential functions of ASPM and TROAP across 31 cancer types. Methods: Based on datasets from The Cancer Genome Atlas (TCGA), Human Protein Atlas (HPA), Gene-Cloud of Biotechnology Information (GCBI) and Gene Expression Omnibus (GEO), we employed an array of bioinformatics methods to explore the potential oncogenic roles of ASPM and TROAP. Results: ASPM and TROAP, which were highly expressed in most cancers and presented a strict positive correlation, led to a decreased life expectancy among cancer patients. ASPM and TROAP both regulated cell replication in the S&G2 phase of the cell cycle. Through a protein-protein interaction network (PPI) analysis of ASPM and TROAP, we found that cell division cycle 20 (CDC20) was regulated by TROAP and functioned upstream of ASPM. Thus, TROAP can regulate the role of ASPM in cancers. Conclusions: The ASPM and TROAP have a significant positive correlation and similar expression profiles, and promote tumor malignancy and development in the S&G2 phase of the cell cycle. Since ASPM is one of the downstream targets of TROAP, TROAP and especially ASPM may be potential tumor makers and promising targets for therapeutic strategy.